Annual report pursuant to Section 13 and 15(d)

Debt (Detail Textuals)

v3.20.4
Debt (Detail Textuals) - USD ($)
1 Months Ended 12 Months Ended
Oct. 05, 2018
Apr. 24, 2020
Nov. 30, 2018
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Debt Instrument [Line Items]            
Derivative liability       $ 38,567 $ 501,400 $ 15,958,366
Convertible multi-draw credit agreement issuance costs       63,007    
Loss on extinguishment of debt       $ (0) $ (725,425)  
Paycheck Protection Program            
Debt Instrument [Line Items]            
Maturity date   Apr. 24, 2022        
Principal amount of promissory Note   $ 116,700        
Interest rate   1.00%        
Excess payroll costs exclude compensation of an individual employee   $ 100,000        
Percentage of forgiveness amount for nonpayroll costs   40.00%        
Amount of salaries   $ 100,000        
Percentage of reduction in annual salary   25.00%        
Multi-Draw Credit Agreement            
Debt Instrument [Line Items]            
Warrant exercise price     $ 0.50   $ 0.50  
Proceeds from related party debt     $ 2,000,000   $ 2,000,000  
Number of warrant issued     2,500,000   5,000,000  
Allocation of debt on the basis of relative fair value     $ 1,684,920   $ 3,283,890  
Allocation of warrant on the basis of relative fair value     315,080   716,110  
Beneficial conversion feature     90,080   1,584,850  
Derivative liability     $ 204,102   516,058  
Proceeds from warrant exercises         3,985,500  
Loss on extinguishment of debt         (725,425)  
Fair value of derivative liabilities in excess of proceeds         $ 322,644  
Unamortized debt discount period       1 year 9 months 3 days    
Effective interest rate       98.01% 32.05%  
Fair value of shares underlying convertible debt       $ 201,450    
Principal amount of promissory Note         $ 4,000,000  
Emerald financing            
Debt Instrument [Line Items]            
Derivative liability       38,567 $ 276,024 $ 15,251,413
Emerald financing | Multi-Draw Credit Agreement            
Debt Instrument [Line Items]            
Maximum amount that can be borrowed over the life of the credit facility $ 20,000,000          
Interest rate percentage 7.00%          
Maturity date Oct. 05, 2022          
Unused portion of the credit facility       13,550,000    
Warrant coverage on the debt facility 50.00%          
Warrant exercise price $ 0.50          
Reduced exercise price of warrant 0.35          
Emerald Health Sciences Inc | Multi-Draw Credit Agreement            
Debt Instrument [Line Items]            
Conversion price $ 0.25          
Amount of capital raise $ 5,000,000          
Emerald Health Sciences Inc | Independent contractor agreement            
Debt Instrument [Line Items]            
Credit facility effected fourth advances       150,000    
Credit facility effected fifth advances       $ 300,000